One of the key reasons behind the growing adoption of MEK inhibitors is their ability to specifically target cancer cells while minimizing damage to healthy cells. This is in contrast to traditional chemotherapy, which often causes widespread harm to both cancerous and normal tissues. The growing preference for precision medicine, where therapies are tailored to individual patients based on...